These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7451114)

  • 1. Exposure to radioiodine in the preconception and conception periods. A case report.
    Zaltzman S; Baron J; Werner A; Chaichik S
    Isr J Med Sci; 1980 Dec; 16(12):856-8. PubMed ID: 7451114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report.
    Arndt D; Mehnert WH; Franke WG; Woller P; Laude G; Rockel A; Waller M
    Strahlenther Onkol; 1994 Jul; 170(7):408-14. PubMed ID: 8052940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy testing before high-dose radioiodine treatment: a case report.
    Bohuslavizki KH; Kröger S; Klutmann S; Geiss-Tönshoff M; Clausen M
    J Nucl Med Technol; 1999 Sep; 27(3):220-1. PubMed ID: 10512478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
    Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
    Chow SM; Yau S; Lee SH; Leung WM; Law SC
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute leukemias after treatment with radioiodine for thyroid cancer.
    Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
    Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
    Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
    J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-131 therapy of thyroid cancer: extensive contamination of the hospital room in a patient with tracheostomy.
    Kappes RS; Sarkar SD; Har-El G; Strashun AM; Dunn EK; Schussler GC
    J Nucl Med; 1994 Dec; 35(12):2053-4. PubMed ID: 7989991
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma.
    Balenović A; Vlasić M; Sonicki Z; Bodor D; Kusić Z
    Coll Antropol; 2006 Dec; 30(4):743-8. PubMed ID: 17243543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Necessity to administer 131I in a patient with papillary thyroid carcinoma undergoing chronic hemodialysis].
    Novik V; González R; Díaz M; Vega J
    Rev Med Chil; 1998 Jul; 126(7):874-5. PubMed ID: 9830782
    [No Abstract]   [Full Text] [Related]  

  • 12. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
    Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
    J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved prediction of therapeutic absorbed doses of radioiodine in the treatment of thyroid carcinoma.
    Hermanská J; Kárný M; Zimák J; Jirsa L; Sámal M; Vlcek P
    J Nucl Med; 2001 Jul; 42(7):1084-90. PubMed ID: 11438632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I therapy of thyroid cancer patients.
    Reiners C; Farahati J
    Q J Nucl Med; 1999 Dec; 43(4):324-35. PubMed ID: 10731783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid].
    Kaniewski M; Czetwertyńska M; Godlewska P; Drac-Kaniewska J
    Wiad Lek; 2001; 54 Suppl 1():297-300. PubMed ID: 12182038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic risk after high dose radioiodine therapy with regard to gonadal dose].
    Ehrenheim C; Hauswirth C; Fitschen J; Martin E; Oetting G; Hundeshagen H
    Nuklearmedizin; 1997 Aug; 36(5):157-66. PubMed ID: 9380527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation safety protocol for high dose 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure.
    Modarresifar H; Almodovar S; Bass WB; Ojha B
    Health Phys; 2007 Feb; 92(2 Suppl):S45-9. PubMed ID: 17228187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A glowing report on dialysis.
    Stabroth C; Luft FC
    Nephrol Dial Transplant; 2005 May; 20(5):1005-6. PubMed ID: 15831551
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma.
    Rubino C; Adjadj E; Doyon F; Shamsaldin A; Abbas TM; Caillou B; Colonna M; Cecarreli C; Schvartz C; Bardet S; Langlois C; Ricard M; Schlumberger M; de Vathaire F
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1084-9. PubMed ID: 15990012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.